- Tytuł:
- Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study
- Autorzy:
- Źródło:
- In Clinical Lymphoma, Myeloma and Leukemia March 2024 24(3):194-202
Czasopismo naukowe